Predictive value of serum CA-125 levels in patients with persistent or recurrent epithelial ovarian cancer or peritoneal cancer treated with bevacizumab on a Gynecologic Oncology Group phase II trial
about
Profile of bevacizumab in the treatment of platinum-resistant ovarian cancer: current perspectivesRecurrence patterns after extended treatment with bevacizumab for ovarian, fallopian tube, and primary peritoneal cancers.The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancerCurrent status of bevacizumab in advanced ovarian cancerCurrent approaches and challenges in managing and monitoring treatment response in ovarian cancer.Poor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: analysis of the AURELIA trial.
P2860
Predictive value of serum CA-125 levels in patients with persistent or recurrent epithelial ovarian cancer or peritoneal cancer treated with bevacizumab on a Gynecologic Oncology Group phase II trial
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Predictive value of serum CA-1 ...... Oncology Group phase II trial
@ast
Predictive value of serum CA-1 ...... Oncology Group phase II trial
@en
type
label
Predictive value of serum CA-1 ...... Oncology Group phase II trial
@ast
Predictive value of serum CA-1 ...... Oncology Group phase II trial
@en
prefLabel
Predictive value of serum CA-1 ...... Oncology Group phase II trial
@ast
Predictive value of serum CA-1 ...... Oncology Group phase II trial
@en
P2093
P2860
P921
P1433
P1476
Predictive value of serum CA-1 ...... Oncology Group phase II trial
@en
P2093
Barbara Buening
Bradley J Monk
Joel I Sorosky
Leslie M Randall
Michael W Sill
Robert A Burger
P2860
P304
P356
10.1016/J.YGYNO.2011.11.035
P407
P577
2011-12-01T00:00:00Z